Inhibition of GROα-induced human endothelial cell proliferation by the α-chemokine inhibitor antileukinate

Cytokine

Volumn 11, Issue 3, 1999, Pages 231-238

  Fujisawa, Nobumitsu ^a   Hayashi, Shinichiro ^b   Kurdowska, Anna ^a   Carr, Ferdicia K ^a   Miller, Edmund J ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Antileukinate; GRO ; Human umbilical vein endothelial cells; IL 8; Proliferation

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE RECEPTOR; HEXAPEPTIDE; IODINE 125; MITOGENIC AGENT; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 8; ANTILEUKINATE; CHEMOTACTIC FACTOR; CXC CHEMOKINE IP 10; CXC CHEMOKINE IP-10; CXCL1 PROTEIN, HUMAN; GROWTH PROMOTOR; INTERLEUKIN 8; OLIGOPEPTIDE; RECOMBINANT PROTEIN; SIGNAL PEPTIDE;

ANGIOGENESIS; ARTICLE; BINDING SITE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; TUMOR GROWTH; UMBILICAL VEIN; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; CYTOLOGY; DRUG ANTAGONISM; METABOLISM; SERODIAGNOSIS; VASCULAR ENDOTHELIUM;

ANTIBODIES, MONOCLONAL; CELL DIVISION; CELLS, CULTURED; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; ENDOTHELIUM, VASCULAR; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-8; NEUTRALIZATION TESTS; OLIGOPEPTIDES; RECEPTORS, CHEMOKINE; RECOMBINANT PROTEINS;

EID: 0033089138     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0418     Document Type: Article

References (39)

1. Richmond A, Lawson DH, Nixon DW, Stevens JS, Chawla RK (1983) Extraction of a melanoma growth-stimulatory activity from culture medium conditioned by the hs0294 human melanoma cell line. Cancer Res 43:2106-2112.
2. Richmond A, Lawson DH, Nixon DW, Stevens JS, Chawla RK (1985) Characterization of autostimulatory and transforming growth factors from human melanoma cells. Cancer Res 45:6390-6394.
3. Richmond A, Thomas HG (1986) Purification of melanoma growth stimulatory activity. J Cell Physiol 129:375-384.
4. Baggiolini M, Dewald B, Moser B (1993) Interleukin-8 related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 55:97-197.
5. Lindley I, Aschauer H, Seifert JM, Lam C, Brunowski W, Kownatzki E, Thelen M, Peveri P, Dewald B, VonTscharner V, Walz A, Baggiolini M (1988) Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biologic equivalence between natural and recombinant neutrophil-activating factor. Proc Natl Acad Sci USA 85:9199-9203.
6. Lawson DH, Thomas HG, Roy RG, Gordon DS, Chawla RK, Nixon DW, Richmond A (1987) Preparation of a monoclonal antibody to a melanoma growth stimulatory activity released into serum-free culture medium by Hs294 malignant melanoma cells. J Cell Biochem 34:169-185.
7. Schröder JM, Peterson NLM, Christophers E (1990) Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide-1/interleukin-8, a second neutrophil-activating protein with growth stimulatory activity. J Exp Med 171:1091-1100.
8. Strieter RM, Polverini PJ, Arenberg DA, Waltz A, Opdenakker G, Damme JV, Kumkel SL (1992) Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leuko Biol 57:752-762.
9. Cuenca RE, Azizkhan RG, Haskill S (1992) Characterization of GROα, β and γ expression in human colonic tumors: Potential significance of cytokine involvement. Surg Oncol 1: 323-329.
10. Murphy PM, Tiffany HL (1991) Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253:1280-1283.
11. Moser B, Barella L, Mattei S, Schumacher C, Boulay F, Colombo MP, Baggiolini M (1993) Expression of transcripts for two interleukin-8 receptors in human phagocytes, lymphocytes and melanoma cells. Biochem J 294:285-292.
12. Hayashi S, Kurdowska A, Miller EJ, Albright ME, Girten BE, Cohen AB (1994) Synthetic hexa- and heptapeptides which inhibit IL-8 from binding to activating human blood neutrophils. J Immunol 154:814-824.
13. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Damme JV, Walz A, Marriott D, Chan SY, Roczniak S, Shanafelt AB (1995) The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270:27348-27357.
14. Arenberg DA, Kunkel SL, Polverini PJ, Morris SB, Burdick MD, Glass MC, Taub DT, Iannettoni MD, Whyte RI, Strieter RM (1996) Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastasis. J Exp Med 184:981-992.
15. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Strieter RM (1996) Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 97:2792-2802.
16. Hu De, Hori Y, Fan TPD (1993) Interleukin-8 stimulates angiogenesis in rats. Inflammation 17:135-143.
17. Cao Y, Chen C, Weatherbee JA, Tsang M, Folkman J (1995) Gro-β, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J Exp Med 182:2069-2077.
18. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798-1801.
19. Petzelbauer P, Watson CA, Pfau SE, Pober JS (1995) IL-8 and angiogenesis: Evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. Cytokine 7:267-272.
20. Sing RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ (1994) Expression of interleukin 8 correates with the metastatic potential of human melanoma cell in nude mice. Cancer Res 54:3242-3247.
21. Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267:10931-10934.
22. Kim JK, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362:841-844.
23. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA, Stricter RM (1994) Inhibition of IL-8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 179:1409-1415.
24. Ueki N, Nakazato M, Ohkawa T, Ikeda T, Amuro Y, Hada T, Higashino K (1992) Expressive production of TGF-β can play an important role in the development of tumorigenesis by its action for angiogenesis: Validity of neutralizing antibodies to block tumor growth. Bichem Biophys Acta 1137:189-196.
25. Matsuzaki K, Yoshitake Y, Matsuo Y, Sasaki H, Nishikawa K (1989) Monoclonal antibodies against heparin binding growth factor II/basic fibroblast growth factor that block its biological activity: Invalidity of the antibodies for tumor angiogenesis. Proc Natl Acad Sci USA 86:9911-9915.
26. Good DJ, Poverini PJ, Rastinejad F, LeBeau MM, Lemons RS, Frazier WA, Bouck NP (1990) A tumor suppresser-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87:6624-6628.
27. O'Reilly MS, Holmgren, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma. Cell 79:315-328.
28. L'Heureux GP, Bourgoin S, Jean N, McColl SR, Naccache PH (1995) Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: Interleukin-8, but not NAP-2 or GROα, stimulates phospholipase D activity. Blood 85:522-531.
29. Damaj BB, McColl SR, Neote K, Hébert CA, Naccache PH (1996) Diverging signal transduction pathways activated by interleukin-8 (IL-8) and related chemokines in human neutrophils: IL-8 and GRO-α differentially stimulate calcium influx through IL-8 receptors A and B. J Biol Chem 271:20540-20544.
30. Rot A (1992) Endothelial cell binding of NAP/IL-8: Role in neutrophil emigration. Immunol Today 13:291-294.
31. Hechtman DH, Cybulsky MI, Fuchs HJ, Baker JB, Gimbrone MA (1991) Intravascular IL-8: Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J Immunol 147:883-892.
32. Hayashi S, Kurdowska A, Cohen AB, Stevens MD, Fujisawa N, Miller EJ (1997) A synthetic peptide inhibitor for α-chemokines inhibits the growth of melanoma cell lines. J Clin Invest 99:2581-2587.
33. Norgauger J, Metzner B, Schraufstätter I (1996) Expression and growth-promoting function of the IL-8 receptor β in human melanoma cells. J Immunol 157:1132-1137.
34. Mosmann T (1983) Rapid calorimetric assay for cellular growth and survival: Applications to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
35. Sylvester I, Rankin JA, Yoshimura T, Tanaka S, Leonard EJ (1990) Secretion of neutrophil attractant/activation protein by lipopolysaccharide-stimulated lung macrophages determined by both enzyme-linked immunosorbent assay and N-terminal sequence analysis. Am Rev Respir Dis 141:683-686.
36. Miller EJ, Nagao S, Carr FK, Noble JM, Cohen AB (1996) Interleukin-8 (IL-8) is a major neutrophil chemotaxin from human alveolar macrophages stimulated with staphylococcal enterotoxin A (SEA). Inflamm Res 45:386-392.
37. Hunter WM, Greenwood FC (1962) Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 194:45-48.
38. Bolton AE, Hunter WM (1973) The labeling of proteins to high specific radioactivities by conjugation to a 125-I-containing acylating agent: Application to the radioimmunoassay. Biochem J 133:529-539.
39. Presta M, Belleri M, Vecchi A, Hesselgesser J, Mantovani A, Horuk R (1998) Nonocompetetive, chemokine-mediated inhibition of basic fibroblast growth factor-induced endothelial cell proliferation. J Biol Chem 273:7911-7919.